Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves once-daily Olumiant tablets for treatment of adults with active RA

cphi-onlineFebruary 16, 2017

Tag: Lilly , active RA

PharmaSources Customer Service